These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20332059)

  • 1. The role of asymmetric binding in ligand-receptor systems with 1:2 interaction ratio.
    Míguez DG
    Biophys Chem; 2010 May; 148(1-3):74-81. PubMed ID: 20332059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition events involved in the activation of the growth hormone receptor by growth hormone.
    Behncken SN; Waters MJ
    J Mol Recognit; 1999; 12(6):355-62. PubMed ID: 10611645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covering a broad dynamic range: information processing at the erythropoietin receptor.
    Becker V; Schilling M; Bachmann J; Baumann U; Raue A; Maiwald T; Timmer J; Klingmüller U
    Science; 2010 Jun; 328(5984):1404-8. PubMed ID: 20488988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
    Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
    Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of alpha-helical cytokine-receptor complexes: we've only scratched the surface.
    Walter MR
    Biotechniques; 2002 Oct; Suppl():46-8, 50-7. PubMed ID: 12395927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.
    Bobrovnik SA
    J Mol Recognit; 2007; 20(4):253-62. PubMed ID: 17847051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New capabilities in determining the binding parameters for ligand-receptor interaction.
    Bobrovnik S
    J Biochem Biophys Methods; 2005 Oct; 65(1):30-44. PubMed ID: 16188321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction.
    Philo JS; Aoki KH; Arakawa T; Narhi LO; Wen J
    Biochemistry; 1996 Feb; 35(5):1681-91. PubMed ID: 8634300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of signalling through cytokine receptors depends critically on receptor orientation.
    Syed RS; Reid SW; Li C; Cheetham JC; Aoki KH; Liu B; Zhan H; Osslund TD; Chirino AJ; Zhang J; Finer-Moore J; Elliott S; Sitney K; Katz BA; Matthews DJ; Wendoloski JJ; Egrie J; Stroud RM
    Nature; 1998 Oct; 395(6701):511-6. PubMed ID: 9774108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonequilibrium, multiple-timescale simulations of ligand-receptor interactions in structured protein systems.
    Zhang Y; Peters MH; Li Y
    Proteins; 2003 Aug; 52(3):339-48. PubMed ID: 12866048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.
    Livnah O; Stura EA; Johnson DL; Middleton SA; Mulcahy LS; Wrighton NC; Dower WJ; Jolliffe LK; Wilson IA
    Science; 1996 Jul; 273(5274):464-71. PubMed ID: 8662530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif.
    Jensen GA; Andersen OM; Bonvin AM; Bjerrum-Bohr I; Etzerodt M; Thøgersen HC; O'Shea C; Poulsen FM; Kragelund BB
    J Mol Biol; 2006 Sep; 362(4):700-16. PubMed ID: 16938309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple mathematical model of cooperativity in receptor mosaics based on the "symmetry rule".
    Agnati LF; Tarakanov AO; Guidolin D
    Biosystems; 2005 May; 80(2):165-73. PubMed ID: 15823415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure of human erythropoietin and a comparison with its receptor bound conformation.
    Cheetham JC; Smith DM; Aoki KH; Stevenson JL; Hoeffel TJ; Syed RS; Egrie J; Harvey TS
    Nat Struct Biol; 1998 Oct; 5(10):861-6. PubMed ID: 9783743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allovalency revisited: an analysis of multisite phosphorylation and substrate rebinding.
    Locasale JW
    J Chem Phys; 2008 Mar; 128(11):115106. PubMed ID: 18361621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.
    Livnah O; Johnson DL; Stura EA; Farrell FX; Barbone FP; You Y; Liu KD; Goldsmith MA; He W; Krause CD; Pestka S; Jolliffe LK; Wilson IA
    Nat Struct Biol; 1998 Nov; 5(11):993-1004. PubMed ID: 9808045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints.
    Selent J; Bauer-Mehren A; López L; Loza MI; Sanz F; Pastor M
    Mol Pharmacol; 2010 Feb; 77(2):149-58. PubMed ID: 19903829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Packing density of the erythropoietin receptor transmembrane domain correlates with amplification of biological responses.
    Becker V; Sengupta D; Ketteler R; Ullmann GM; Smith JC; Klingmüller U
    Biochemistry; 2008 Nov; 47(45):11771-82. PubMed ID: 18855427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncovalent interactions: defining cooperativity. Ligand binding aided by reduced dynamic behavior of receptors. Binding of bacterial cell wall analogues to ristocetin A.
    Williams DH; Davies NL; Zerella R; Bardsley B
    J Am Chem Soc; 2004 Feb; 126(7):2042-9. PubMed ID: 14971938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.